Skip to main content

Table 1 Table of included studies

From: Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review

Study

Number of patients

Gestational Age (Mean + range)

Sex male %

Study Design

Prevalence of infection (%)

Biomarkers

Cut-off

Sens % (95%CI)

Spec % (95%CI)

Studies in newborns

Sarafidis et al. 2010 [17]

52

Infected

35 (24–40) weeks

Infected

57,1%

Prospective

60%

sTREM-1

(ELISA, Quantikine)

143 pg/ml

70 (51-85)

71 (47-88)

31 infected

22 confirmed sepsis

9 possible sepsis

IL-6

66 pg/ml

80 (61-92)

81 (58-94)

Non-infected

30 (24–39) weeks

Non-infected

61.2%

21 non infected

sTREM-1/IL-6

144/66

90 (73-98)

62 (38-82)

Schlapbach et al. 2013 [18]

137

Infected

39.9 (34.0–41.6)

Infected

55%

Prospective

24%

Infected

sTREM-1 (ELISA in-house)

1.25 pg/ml

75

52

CRP

20 mg/L

36

89

PCT

2 ng/ml

88

51

MIF

50 ng/ml

84

62

PSP

9 ng/ml

79

30

Non-infected

38.9 (34.0–42.0)

Non-infected

65%

3 proven infection

PSP+PCT

 

100

28

>/=1

30 probable infections

68

90

2

104 uninfected

PSP+PCT+sTREM

  

>/= 1

100

22

>/= 2

91

51

3

55

93

 

PSP+PCT+sTREM

100

22

+CRP

>/= 1

>/= 2

91

49

>/= 3

59

86

4

32

97

Mazzucchelli et al. 2013 [19]

16 patients who developed sepsis among 70 observed patients

Infected

27.5 ± 2.7 weeks

Infected

56.25%

Prospective

22.85%

TREM-1 expression on PMNs by flow cytometer analysis

Absolute levels not significant

56.2%

93.7%

   

16 patients with culture proven sepsis

 

% of expression of TREM on PMN was evaluated 62.12%

  

16 controls chosen among the same 70 observed patients

Controls

26.9 ± 1.0 weeks

Controls

43.75%

16 patient free of infection matched for sex and age

CD64

2.85

87.5%

100%

Adly et al. 2014 [20]

112 septic patients

Culture proven

35+/-3 weeks

Culture proven

53.9%

Prospective

100% (by study definition)

sTREM1 (ELISA, Quantikine)

310 pg/mL

100

100

40 controls

Culture negative

35.9+/-2,7 weeks

Culture negative

51%

56.3% culture proven

1100 pg/mL (for the prediction of survival)

100

97

 

Controls

35.4+/-2 weeks

Controls 55%

43.7% culture negative

CRP

13.5 mg/L

76

72

Studies in children

Chen et al. 2008 [21]

44

Infants with SBI

51.8+/-31.2 day/old

Infants with SBI

69.56%

Prospective

52.27%

sTREM-1 (ELISA, Quantikine)

24.4 pg/ml

87 (78-97)

81 (69-93)

  

4.55% bacteraemia

Infants without SBI

30.3 +/-30.1 day/old

Infants with SBI

66.6%

4.55% pneumonia

  

4.55% meningitis

38.6% Urinary Tract Infections

Kevan et al. 2011 [22]

24 IF patients

18 months

(3 -58 months)

66.6%

Case control

-

sTREM-1 (ELISA, Quantikine)

-

-

-

Repeated samples (n 65):

- IF: 22

- febrile IF without BSI: 10

- IF + BSI: 17

- IF post-tratment:16

LBP

-

-

-

-Control group: 11

Carrol et al. 2009 [23]

377 patients:

2.3 years,

(0.8 -6.1 years)

57%

Prospective

74%

CRP

10 mg/l

100

13

95 Pneumonia

PCT

0.5 ng/ml

98

27

282 Meningitidis

sTREM-1 (ELISA, Quantikine)

25 pg/ml

87

15

190 HIV+

sCD163

5000 ng/ml

66

38

13 malaria

HMGB1

5 ng/ml

75

40

Studies in neutropenic children

Arzanian et al. 2011 [24]

65

66.2±37 months

53.8%

Prospective

20%

sTREM-1 (ELISA)

525 pg/ml

84.62%

98.08%

Miedema et al. 2011 [25]

29 patients

Bacterial infection

8 years (6-13)

Bacterial infection 36%

Prospective

32.56%

sTREM-1 (ELISA, in-house)

-

-

-

CRP

40 mg/l

t0=69

t0=62

t24-48 h= 100

t24-48 h= 42

43 episodes febrile neutropenia

No bacterial

infection 8 years (6-12)

No bacterial

infection 59%

IL-8

60 ng/l

t0=92

t0=54

PCT

0.25 ng/ml

t24-48 h= 100

t24-48 h= 57

t0=79

t0=77

t24-48 h= 100

t24-48 h= 53

  1. AUC Area under curve; BSI bloodstream infections; CI Confidence interval; CRP C-reactive protein; HMGB1 High-mobility group box 1; IF Intestinal failure; IL-8 Interleukin 8; LBP Lipopolysaccharide-Binding Protein; PSP Pancreatic stone protein; SBI Serious bacterial infection; sTREM-1 Serum soluble triggering receptor on myeloid cells-1